🔴 Solid Biosciences is trading 5% down in pre-market after three consecutive lower closes

Solid Biosciences is trading at $9.05, down -5.14%, amid continued selling pressure after three consecutive lower closes.

• No clear company-specific negative announcement was identified for September 10, 2026; Solid Biosciences was scheduled to participate in a Citi Biopharma conference later that day.
• The broader backdrop remains cautious ahead of U.S. inflation data, with softer technology sentiment and elevated geopolitical risk, though available indicators do not establish a direct cause.